eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

SCImago Journal & Country Rank
vol. 8
Original paper

Id2 protein expression in malignant ovarian tumours

Sylwia Czekierdowska
Artur Czekierdowski
Jan Kotarski

Przegląd Menopauzalny 2009; 1: 20–25
Online publish date: 2009/03/12
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
It has been suggested that various proteins from the “Id” group may play an important role in malignant tumour angiogenesis and metastasis formation. Our aim was to assess whether the expression of Id2 proteins is associated with tumour type, histological grading and FIGO stage in women with malignant ovarian neoplasms. The mean age of 49 patients operated on was 56.1 ±12.7 years (range: 27-80 years) and 18 (36.7%) women in this group were pre-menopausal. Histological examination revealed that more than half of tumours were serous ovarian cancers (n = 26). Other malignancies included 14 mucinous, 5 endometrioid and 4 metastatic tumours. Expression of Id2 protein estimated semiquantitatively (as 1 to 9 points) was found in 40 cases. In 40% of these tumours (n = 17) a high degree of Id2 expression was found. All 9 (19%) tumours without expression of Id2 were serous ovarian cancers. Id2 protein was found in both nuclei and cytoplasm of cancer cells. Also some staining was seen in pericytes adjacent to the microcapillary lumen. In 19 of 25 cases (76%) of low FIGO stage (I and II) tumours Id2 expression was medium or high. Histological grading also had a significant influence (p = 0.009) on Id expression. Most (12 of 18) low-grade tumours (G3) had medium or high Id2 content assessed as 5 to 9 points. Menopausal status had no significant influence on intensity of Id2 staining. High expression of Id2 protein (7 to 9 points) was observed in women before (39%) and after menopause (32%). However, absent Id2 expression was predominantly found in women after menopause (8 of 9 cases). Based on these preliminary results we conclude that the assessment of Id2 protein may be used as an additional parameter to characterize various types of malignant tumours in women.

ovarian cancer, Id proteins, HLH transcriptional factors, angiogenesis

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe